Natalie A Prow
Lorne Infection and Immunity 2018
Days
Wednesday, 14th February
Thursday, 15th February
Friday, 16th February
Search
Speakers
Natalie A Prow
Abstracts this author is presenting:
A new replication-defective, vaccinia-derived, CHO-manufactured, vaccine vector system (SCV) is effective in preclinical studies
—
SESSION 8: Infection and immunity in the clinic